enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Pseudoephedrine - Wikipedia

   en.wikipedia.org/wiki/Pseudoephedrine

   Only a single placebo-controlled study of pseudoephedrine for weight loss exists (120 mg/day slow-release for 12 weeks) and found no significant difference in weight lost compared to placebo (-4.6 kg vs. -4.5 kg).

3. ECA stack - Wikipedia

   en.wikipedia.org/wiki/ECA_stack

   The effects of the ECA stack on weight loss are primarily due to the ephedrine component. Ephedrine acts both as an α and β adrenergic agonist , stimulating the release of norepinephrine . [ 8 ] Increased circulating norepinephrine in the body then acts on brown adipose tissue and skeletal muscle [ 9 ] by increasing cyclic adenosine ...

4. Ephedra (medicine) - Wikipedia

   en.wikipedia.org/wiki/Ephedra_(medicine)

   This study found that ephedra promoted modest short-term weight loss, but there was insufficient data to determine whether it was effective for long-term weight loss or performance enhancement. The use of ephedrine alkaloids in this study was associated with significant gastrointestinal, psychiatric, and autonomic side effects. [36]

5. Prescriptions for weight loss drugs are skyrocketing ... - AOL

   www.aol.com/lifestyle/prescriptions-weight-loss...

   Starting in 2022, Haley Sipes lost 75 pounds over 10 months with diet and exercise alone. On TikTok, where the 31-year-old mother of three chronicled her weight loss journey, commenters speculated ...

6. The Terrible—and Amazing—Side Effects of Weight-Loss Drugs

   www.aol.com/terrible-amazing-side-effects-weight...

   GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. ... and bile duct problems, according to a review in JAMA ...

7. EMA's safety committee recommends label update for certain ...

   www.aol.com/news/emas-safety-committee...

   (Reuters) - The European Medicines Agency's (EMA) safety committee on Friday recommended changes to product information for all medicines that contain the ingredient pseudoephedrine to address ...